Ana Sofia Gregório Fernandes
Professor
Pharmacology
Universidade Lusafona de Humanidades e Tecnologias
Portugal
Biography
Ana Sofia Fernandes (1980) graduated in Pharmaceutical Sciences from the Faculty of Pharmacy of the University of Lisbon (FFUL) in 2004, with a final average of 16 values. In 2010, he completed his PhD in Pharmacy, in the specialty of Toxicology, by the University of Lisbon. She has been a lecturer at ULHT since 2008, teaching several subjects in Toxicology and Pharmacology. She is currently a researcher at CBIOS-ULHT and a collaborator at iMed.UL / FFUL. She is involved in several research projects in the areas of toxicology and the development of potential new drugs, and her main current scientific interest is the study of the influence of redox modulators on cancer progression and antitumor therapy.
Research Interest
Areas of toxicology and the development of potential new drugs and The influence of redox modulators on cancer progression and anti tumor therapy.
Publications
-
CO Silva, P Rijo, J Molpeceres, IV Figueiredo, L Ascension, AS Fernandes, A Roberto, C Reis. Polymeric nanoparticles modified with fatty acids encapsulating betamethasone for anti-inflammatory treatment. International Journal of Pharmaceutics, in press (doi: 10.1016 / j.ijpharm.2015.07.044)
-
Fernandes AS, Florida A, Saraiva N, Cerqueira S, Ramalhete S, Cipriano M, et al. Role of the copper (II) complex Cu [15] pyN5 in intracellular ROS and breast cancer cell motility and invasion. Chem Biol Drug Des. 2015; in press. (doi: 10.1111 / cbdd.12521)
-
Miranda JP, Filipe E, Fernandes AS, et al. The human umbilical cord tissue-derived MSC population UCX® promotes early genetic effects on keratinocytes and fibroblasts and G-CSF-mediated mobilization of BM-MSCs when transplanted in vivo. Cell Transplantion 24 (5): 865-77
